Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Participants
Clinical trial NCT05046132 · COMPLETED
Trial details
- NCT number
- NCT05046132
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-05
- Primary completion
- 2022-04-07
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.